Xcout Intel
Mosanna Therapeutics
Mosanna Therapeutics is a biopharmaceutical company with offices in Redwood City, California and Basel, Switzerland. The company focuses on developing novel treatments for metabolic and cardiovascular diseases. It launched with $80 million in funding to advance its clinical pipeline.
Subscribe to see Mosanna Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mosanna Therapeutics at a glance
Mosanna Therapeutics is a biotechnology company headquartered in Switzerland. Its most recent funding round, Series A, raised $80M in June 2025. Xcout tracks 13 named people at Mosanna Therapeutics, including David Weber (President and Chief Executive Officer).
Mosanna Therapeutics leadership
- David WeberPresident and Chief Executive Officer
- David WhiteConsulting Chief Medical Officer (CMO)
- Sascha Oliver BucherCo-Founder & Partner, Forty51 Ventures
- Barbara FinnSVP Regulatory & Quality Assurance
- David SkarinskySVP Clinical Development
- Kevin KeeVP Pharmaceutical Development
7 more named people on record for Mosanna Therapeutics, with roles, board committees and tenure — see the full roster →
Mosanna Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $80M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Mosanna Therapeutics competitors
A few of Mosanna Therapeutics's closest competitors — see the full list of competitors and alternatives →
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Akero Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company is dedicated to developing transformational therapies for metabolic dysfunction-associated steatohepatitis and other metabolic diseases.
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Metabolic Solutions Development Company is a private biotechnology and drug discovery company founded in 2006. The firm focuses on investigating novel molecular targets and developing therapeutics to treat diabetes, metabolic syndrome, and related conditions.
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Get Mosanna Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Mosanna Therapeutics in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access